Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

VRCA

Verrica Pharmaceuticals Inc

May 08 • 04:00PM ET

7.99

-0.25 -3.03 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: VYNE ARQT SPRO ADAG BDTX

| Held by: VXF VTI DFAS DFAC AVTM

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.61	Insider Own	23.59%	Shs Outstand	17.18M	Perf Week	27.43%
Market Cap	137.26M	Forward P/E	-	EPS next Y	-0.75	Insider Trans	104.54%	Shs Float	8.57M	Perf Month	37.05%
Enterprise Value	108.74M	PEG	-	EPS next Q	-0.45	Inst Own	29.38%	Short Float	6.78%	Perf Quarter	15.63%
Income	-17.89M	P/S	3.86	EPS this Y	14.04%	Inst Trans	29.53%	Short Ratio	4.90	Perf Half Y	131.59%
Sales	35.58M	P/B	5.55	EPS next Y	48.29%	ROA	-35.02%	Short Interest	0.58M	Perf YTD	-3.85%
Book/sh	1.44	P/C	4.55	EPS next 5Y	-	ROE	-240.35%	52W High	9.82 -18.65%	Perf Year	92.44%
Cash/sh	1.76	P/FCF	-	EPS past 3/5Y	38.35% 37.12%	ROIC	-69.79%	52W Low	3.28 143.60%	Perf 3Y	-87.93%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	57.93% -	Gross Margin	90.33%	Volatility	11.39% 8.72%	Perf 5Y	-93.05%
Dividend TTM	-	EV/Sales	3.06	EPS Y/Y TTM	89.54%	Oper. Margin	-33.56%	ATR (14)	0.58	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.33	Sales Y/Y TTM	370.22%	Profit Margin	-50.27%	RSI (14)	67.74	Recom	1.40
Dividend Gr. 3/5Y	- -	Current Ratio	2.47	EPS Q/Q	76.22%	SMA20	19.96%	Beta	1.56	Target Price	16.50
Payout	-	Debt/Eq	0.07	Sales Q/Q	1380.23%	SMA50	34.55%	Rel Volume	0.93	Prev Close	8.24
Employees	76	LT Debt/Eq	0.04	Earnings	May 12 AMC	SMA200	35.51%	Avg Volume	118.62K	Price	7.99
IPO	Jun 15, 2018	Option/Short	No / Yes	EPS/Sales Surpr.	18.86% 12.65%	Trades		Volume	110,354	Change	-3.03%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)